Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Apr 2, 2019 (8 years ago)

Prostaglandin Tri-Mix 30:30:1 Injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of sterility assurance.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Prostaglandin Tri-Mix 30:30:1 Injection, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

Recalling firm
Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy
Origin
TN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1204-2019 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

All 2019 recalls

Other sterility / contamination recalls from 2019

All sterility / contamination recalls